Sort
16,300 grants matching “fatty liver disease”
Role of Uhrf1 in Liver Development, Regeneration and Carciogenesis
$408,198Chinweike Ukomadu · Brigham And Women'S Hospital · R01 · FY2010 · DK
VARIATION IN THE EFFECTS OF ALCOHOL ON LIVER FUNCTION
$407,975Queensland Institute Of Medical Research · R01 · FY2003 · AA
The 11S-associated immunoproteasome in mitochondrial function and metabolic disorders
$407,884Do-Hyung Kim · University Of Minnesota · R01 · FY2023 · DK
The 11S-associated immunoproteasome in mitochondrial function and metabolic disorders
$407,884Do-Hyung Kim · University Of Minnesota · R01 · FY2025 · DK
Pannexin 1 channels in diet-induced metabolic syndrome
$407,863Norbert Leitinger · University Of Virginia · P01 · FY2020 · HL
Anti-inflammatory functions for non-transcriptional IRF3
$407,851Saurabh Chattopadhyay · University Of Kentucky · R01 · FY2025 · AI
Mechanism and application of sugar-induced phage production by the probiotic gut symbiont Lactobacillus reuteri
$407,807Jan-Peter Van Pijkeren · University Of Wisconsin-Madison · R01 · FY2021 · AT
Endothelin-1 in Obesity and Insulin Resistance
$407,650Joshua S Speed · University Of Mississippi Med Ctr · R01 · FY2022 · DK
Endothelin-1 in Obesity and Insulin Resistance
$407,650Joshua S Speed · University Of Mississippi Med Ctr · R01 · FY2023 · DK
Endothelin-1 in Obesity and Insulin Resistance
$407,650Joshua S Speed · University Of Mississippi Med Ctr · R01 · FY2021 · DK
Endothelin-1 in Obesity and Insulin Resistance
$407,650Joshua S Speed · University Of Mississippi Med Ctr · R01 · FY2025 · DK
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis
$407,378Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2012 · AA
Visceral Adiposity, HIV, and HCV: Biologic Mediators of Hepatic Steatosis
$407,297Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2013 · AI
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease
$406,856Wanqing Liu · Wayne State University · R01 · FY2017 · DK
Defining the roles of ACAD10/11 in hydroxy lipid catabolism and metabolic disease
$406,853David J Pagliarini · Washington University · R01 · FY2025 · DK
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
$406,851Jyothi Unnikrishna Menon · University Of Rhode Island · R37 · FY2024 · CA
Epigenetic Control of SMC Transitions to a Multi-Potential Stem Cell-Like State
$406,850Gary K Owens · University Of Virginia · R01 · FY2016 · HL
Thioesterase-mediated lipotoxicity in liver and thermogenic adipose tissue
$406,800Baran Ersoy · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
$406,800Natalia Nieto · Icahn School Of Medicine At Mount Sinai · U01 · FY2012 · AA
Membrane signaling protein modulation by lipids and drugs
$406,794Daniel Rosenbaum · Ut Southwestern Medical Center · R35 · FY2022 · GM
Membrane signaling protein modulation by lipids and drugs
$406,794Daniel Rosenbaum · Ut Southwestern Medical Center · R35 · FY2024 · GM
Membrane signaling protein modulation by lipids and drugs
$406,794Daniel Rosenbaum · Ut Southwestern Medical Center · R35 · FY2023 · GM
Lipid Aldehyde and Ethanol Induced Liver Damage
$406,791Dennis Petersen · University Of Colorado Denver · R37 · FY2011 · AA
Pediatric Trials in Non-Alcoholic Steatohepatitis (NASH)
$406,782University Of California San Diego · U01 · FY2004 · DK
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis
$406,770Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2011 · AA